<VariationArchive RecordType="classified" VariationID="16315" VariationName="NG_012690.2:g.4664_16889del" VariationType="Deletion" Accession="VCV000016315" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-07-17" DateCreated="2015-08-15" MostRecentSubmission="2015-08-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31354" VariationID="16315">
      <GeneList>
        <Gene Symbol="FMO3" FullName="flavin containing dimethylaniline monoxygenase 3" GeneID="2328" HGNC_ID="HGNC:3771" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>1q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="171090905" stop="171117819" display_start="171090905" display_stop="171117819" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="171060017" stop="171086958" display_start="171060017" display_stop="171086958" Strand="+" />
          </Location>
          <OMIM>136132</OMIM>
        </Gene>
      </GeneList>
      <Name>NG_012690.2:g.4664_16889del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q23-q25</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>2-EX DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012690.2" sequenceAccession="NG_012690" sequenceVersion="2" change="g.4664_16889del">
            <Expression>NG_012690.2:g.4664_16889del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="FMO3_000091" DB="LOVD 3" />
        <XRef Type="Allelic variant" ID="136132.0012" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 136132.0012 from the description in the paper by Forrest et al., 2001 (PubMed 11266081) that the deletion began 328 bp upstream of the transcription start site defined by Z47552 and extended for 12226 bp.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_012690.2:g.4664_16889del AND Trimethylaminuria" Accession="RCV000017708" Version="28">
        <ClassifiedConditionList TraitSetID="5286">
          <ClassifiedCondition DB="MedGen" ID="C0342739">Trimethylaminuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-08-15" MostRecentSubmission="2015-08-15">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11266081</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5286" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3918" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Fish malodor syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Stale fish syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TMAuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FISH-ODOR SYNDROME</ElementValue>
                <XRef Type="MIM" ID="602079" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Trimethylaminuria</ElementValue>
                <XRef ID="Trimethylaminuria/7223" DB="Genetic Alliance" />
                <XRef ID="HP:0003614" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0011182" DB="MONDO" />
                <XRef ID="237959005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TMAU</ElementValue>
                <XRef Type="MIM" ID="602079" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000505067" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518973" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520120" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6447" />
                <XRef ID="6447" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Primary trimethylaminuria is characterized by a fishy odor resembling that of rotten or decaying fish that results from excess excretion of trimethylamine in the urine, breath, sweat, and reproductive fluids. No physical symptoms are associated with trimethylaminuria. Affected individuals appear normal and healthy; however, the unpleasant odor often results in social and psychological problems. Symptoms are usually present from birth and may worsen during puberty. In females, symptoms are more severe just before and during menstruation, after taking oral contraceptives, and around the time of menopause.</Attribute>
                <XRef ID="NBK1103" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301282</ID>
                <ID Source="BookShelf">NBK1103</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">22126753</ID>
              </Citation>
              <XRef ID="C0342739" DB="MedGen" />
              <XRef ID="MONDO:0011182" DB="MONDO" />
              <XRef Type="MIM" ID="602079" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003614" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37985" SubmissionDate="2015-08-12" DateLastUpdated="2015-08-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="136132.0012_TRIMETHYLAMINURIA" title="FMO3, 2-EX DEL_TRIMETHYLAMINURIA" />
        <ClinVarAccession Accession="SCV000037985" DateUpdated="2015-08-15" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Forrest et al. (2001) described trimethylaminuria (TMAU; 602079) caused by a deletion of more than 12 kb in the FMO3 gene in a 15-year-old Australian male of Greek parents. The deletion began 328 bp upstream from exon 1; the 3-prime end of the deletion occurred in intron 2. The deletion was 12,226 bp long. Because of homozygosity for the FMO3 gene deletion, it was predicted that in addition to loss of monooxygenase function for human FMO3 substrates, such as trimethylamine and other amines, the proband would exhibit decreased tolerance of biogenic amines, both medicinal and dietary.</Attribute>
              <Citation>
                <ID Source="PubMed">11266081</ID>
              </Citation>
              <XRef DB="OMIM" ID="602079" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FMO3" />
          </GeneList>
          <Name>FMO3, 2-EX DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-EX DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="136132.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TRIMETHYLAMINURIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37985" TraitType="Disease" MappingType="Name" MappingValue="TRIMETHYLAMINURIA" MappingRef="Preferred">
        <MedGen CUI="C0342739" Name="Trimethylaminuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

